Group One Trading
HZNP

Group One Trading’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Group One Trading’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,400,200
Closed -$162M – 8522
2023
Q3 		$162M Sell
1,400,200
-118,900
-8% -$12.8M 0.54% 19
2023
Q2 		$156M Buy
1,519,100
+1,251,700
+468% +$132M 0.5% 21
2023
Q1 		$29.2M Buy
267,400
+90,200
+51% +$9.97M 0.11% 133
2022
Q4 		$20.2M Buy
177,200
+136,500
+335% +$11.3M 0.05% 405
2022
Q3 		$2.52M Sell
40,700
-29,400
-42% -$2.05M 0.01% 1707
2022
Q2 		$5.59M Buy
70,100
+7,700
+12% +$729K 0.01% 1216
2022
Q1 		$6.57M Sell
62,400
-14,500
-19% -$1.41M 0.01% 1320
2021
Q4 		$8.29M Buy
76,900
+24,100
+46% +$2.63M 0.01% 1262
2021
Q3 		$5.78M Sell
52,800
-81,300
-61% -$8.44M 0.01% 1547
2021
Q2 		$12.6M Sell
134,100
-223,300
-62% -$20.5M 0.02% 920
2021
Q1 		$32.9M Buy
357,400
+114,100
+47% +$9.63M 0.05% 343
2020
Q4 		$17.8M Buy
243,300
+81,300
+50% +$6.04M 0.03% 501
2020
Q3 		$12.6M Buy
162,000
+157,100
+3,206% +$10.8M 0.04% 429
2020
Q2 		$272K Sell
4,900
-23,300
-83% -$997K ﹤0.01% 3133
2020
Q1 		$835K Sell
28,200
-40,400
-59% -$1.37M 0.01% 1657
2019
Q4 		$2.48M Buy
68,600
+32,500
+90% +$996K 0.02% 1137
2019
Q3 		$983K Buy
36,100
+14,600
+68% +$378K 0.01% 1755
2019
Q2 		$517K Sell
21,500
-12,000
-36% -$304K ﹤0.01% 2098
2019
Q1 		$885K Sell
33,500
-24,900
-43% -$590K 0.01% 1499
2018
Q4 		$1.14M Buy
58,400
+200
+0.3% +$3.92K 0.01% 1414
2018
Q3 		$1.14M Sell
58,200
-4,000
-6% -$76K 0.01% 1602
2018
Q2 		$1.03M Sell
62,200
-36,300
-37% -$554K 0.01% 1697
2018
Q1 		$1.4M Buy
98,500
+11,200
+13% +$165K 0.01% 1255
2017
Q4 		$1.27M Buy
87,300
+29,000
+50% +$407K 0.01% 1526
2017
Q3 		$739K Sell
58,300
-19,000
-25% -$242K 0.01% 1785
2017
Q2 		$918K Sell
77,300
-126,700
-62% -$1.58M 0.01% 1528
2017
Q1 		$3.02M Sell
204,000
-798,900
-80% -$12.9M 0.04% 626
2016
Q4 		$16.2M Buy
1,002,900
+670,700
+202% +$12.2M 0.16% 130
2016
Q3 		$6.02M Buy
332,200
+178,300
+116% +$3.48M 0.07% 338
2016
Q2 		$2.54M Sell
153,900
-105,700
-41% -$1.71M 0.03% 684
2016
Q1 		$4.3M Sell
259,600
-18,000
-6% -$315K 0.06% 399
2015
Q4 		$6.02M Buy
277,600
+120,900
+77% +$2.35M 0.07% 306
2015
Q3 		$3.11M Buy
156,700
+106,100
+210% +$3.35M 0.04% 553
2015
Q2 		$1.76M Sell
50,600
-36,400
-42% -$1.11M 0.02% 836
2015
Q1 		$2.26M Buy
87,000
+10,500
+14% +$192K 0.04% 578
2014
Q4 		$986K Sell
76,500
-69,100
-47% -$865K 0.01% 1087
2014
Q3 		$1.79M Buy
145,600
+50,200
+53% +$583K 0.03% 752
2014
Q2 		$1.51M Buy
95,400
+20,800
+28% +$297K 0.02% 870
2014
Q1 		$1.13M Buy
74,600
+50,800
+213% +$574K 0.02% 995
2013
Q4 		$181K Buy
23,800
+3,100
+15% +$16.7K ﹤0.01% 2524
2013
Q3 		$70K Buy
20,700
+5,700
+38% +$15K ﹤0.01% 3306
2013
Q2 		$37K Buy
+15,000
New +$36K ﹤0.01% 3698

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Group One Trading's HZNP Position: Q4 2023 in Review

Group One Trading sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 25,845 shares — an estimated $2.99M sold.

Group One Trading first reported a position in HZNP in Q2 2013 and held it in 29 quarters. The position peaked at $10.1M in Q1 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Group One Trading reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Group One Trading sold 25,845 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $2.99M.
  • Group One Trading first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2013 and held it in 29 quarters.
  • Group One Trading's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $10.1M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Group One Trading's 13F filing for Q4 2023, filed 14 Feb 2024.